Maxcyte reported revenue of $7.27M and net income of -$8.87M for the quarter ended Jun 2026, down 14.5% year over year. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 100.43M | 101.20M | 101.51M | 101.66M | 101.90M | 102.40M | 102.90M | 103.13M | 103.55M | 103.96M | 104.41M | 104.82M | 105.30M | 105.71M | 106.31M | 106.59M | 106.64M | 106.79M | 107.12M | 106.13M | |||||
| Revenue & cost | |||||||||||||||||||||||||
| Revenue | 10.14M | 10.15M | 11.59M | 9.61M | 10.64M | 12.42M | 8.58M | 9.04M | 8.00M | 15.66M | 11.34M | 10.43M | 8.16M | 8.69M | 10.39M | 8.51M | 6.83M | 7.30M | 9.65M | 7.27M | |||||
| Gross Profit | 9.20M | 8.93M | 10.52M | 8.49M | 9.27M | 10.88M | 7.58M | 7.67M | 7.21M | 14.09M | 9.94M | 8.94M | 6.24M | 6.41M | 8.89M | 6.99M | 5.23M | 5.69M | 8.08M | 5.60M | |||||
| Operating items | |||||||||||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 1.08M | 1.07M | 1.06M | 1.09M | 1.09M | 1.06M | 1.05M | 1.03M | 0.96M | ||||||||||||||||
| Research & DevelopmentR&D | 3.21M | 3.38M | 3.84M | 4.93M | 5.33M | 5.73M | 6.30M | 6.44M | 7.05M | 7.20M | 7.37M | 6.62M | 6.21M | 6.47M | 5.90M | 6.27M | 5.32M | 3.33M | 3.86M | 4.25M | |||||
| Selling, General & AdministrativeSG&A | 5.35M | 6.03M | 6.63M | 7.10M | 6.44M | 5.65M | 7.50M | 7.66M | 6.82M | 8.09M | 7.10M | 7.64M | 7.75M | 7.21M | 8.53M | 8.08M | 6.03M | 5.48M | 5.97M | 7.26M | |||||
| Restructuring CostsRestructuring | 3.06M | ||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 3.08M | 4.47M | 4.21M | 5.19M | 5.22M | 6.25M | 6.96M | 6.64M | 7.30M | 6.91M | 7.75M | 5.57M | 5.27M | 4.58M | 5.67M | 5.78M | 3.92M | 7.04M | 3.41M | 3.36M | |||||
| Operating ExpensesOpex | 11.64M | 13.88M | 14.68M | 17.23M | 16.99M | 17.63M | 20.75M | 20.74M | 21.16M | 22.19M | 22.21M | 20.91M | 20.29M | 19.31M | 21.19M | 21.21M | 19.38M | 16.92M | 14.27M | 15.83M | |||||
| Operating IncomeOp. Inc | -2.44M | -4.96M | -4.16M | -8.74M | -7.71M | -6.75M | -13.18M | -13.07M | -13.95M | -8.10M | -12.28M | -11.97M | -14.05M | -12.90M | -12.29M | -14.23M | -14.15M | -11.23M | -6.18M | -10.23M | |||||
| EBIT | -2.44M | -4.96M | -4.16M | -8.74M | -7.71M | -6.75M | -13.18M | -13.07M | -13.95M | -8.10M | -12.28M | -11.97M | -14.05M | -12.90M | -12.29M | -14.23M | -14.15M | -11.23M | -6.18M | -10.23M | |||||
| Non-operating items | |||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.29M | 0.12M | 0.01M | ||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.05M | 0.08M | 0.09M | 0.48M | 1.39M | 1.95M | 2.30M | 2.56M | 2.70M | 2.82M | 2.75M | 2.59M | 2.50M | 2.30M | 2.03M | 1.87M | 1.73M | 1.63M | 1.44M | 1.36M | |||||
| Other Non Operating IncomeOther Non Op Inc. | -0.24M | 0.08M | 0.09M | 0.48M | 1.28M | 1.94M | 2.30M | 2.56M | 2.70M | 2.82M | 2.75M | 2.59M | 2.50M | 2.30M | 2.03M | 1.87M | 1.73M | 1.63M | 1.44M | 1.36M | |||||
| Net income details | |||||||||||||||||||||||||
| EBT | -2.68M | -4.87M | -4.07M | -8.26M | -6.43M | -4.81M | -10.88M | -10.51M | -11.25M | -5.28M | -9.53M | -9.38M | -11.56M | -10.60M | -10.26M | -12.36M | -12.42M | -9.60M | -4.75M | -8.87M | |||||
| Profit After TaxPAT | -2.68M | -4.87M | -4.07M | -8.26M | -6.43M | -4.81M | -10.88M | -10.51M | -11.25M | -5.28M | -9.53M | -9.38M | -11.56M | -10.60M | -10.26M | -12.36M | -12.42M | -9.60M | -4.75M | -8.87M | |||||
| Income from Continuing OperationsIncome (Continuing) | -2.68M | -4.87M | -4.07M | -8.26M | -6.43M | -4.81M | -10.88M | -10.51M | -11.25M | -5.28M | -9.53M | -9.38M | -11.56M | -10.60M | -10.26M | -12.36M | -12.42M | -9.60M | -4.75M | -8.87M | |||||
| Consolidated Net IncomeConsol Net Inc. | -2.68M | -4.87M | -4.07M | -8.26M | -6.43M | -4.81M | -10.88M | -10.51M | -11.25M | -5.28M | -9.53M | -9.38M | -11.56M | -10.60M | -10.26M | -12.36M | -12.42M | -9.60M | -4.75M | -8.87M | |||||
| Income towards Parent CompanyParent Net Inc | -2.68M | -4.87M | -4.07M | -8.26M | -6.43M | -4.81M | -10.88M | -10.51M | -11.25M | -5.28M | -9.53M | -9.38M | -11.56M | -10.60M | -10.26M | -12.36M | -12.42M | -9.60M | -4.75M | -8.87M | |||||
| Net Income towards Common StockholdersNet Income | -2.68M | -4.87M | -4.07M | -8.26M | -6.43M | -4.81M | -10.88M | -10.51M | -11.25M | -5.28M | -9.53M | -9.38M | -11.56M | -10.60M | -10.26M | -12.36M | -12.42M | -9.60M | -4.75M | -8.87M | |||||
| Additional items | |||||||||||||||||||||||||
| EPS (Basic) | -0.03 | -0.05 | -0.04 | -0.08 | -0.06 | -0.05 | -0.11 | -0.10 | -0.11 | -0.05 | -0.09 | -0.09 | -0.11 | -0.10 | -0.10 | -0.12 | -0.12 | -0.09 | -0.04 | -0.08 | |||||
| EPS (Diluted) | -0.03 | -0.05 | -0.04 | -0.08 | -0.06 | -0.05 | -0.11 | -0.10 | -0.11 | -0.05 | -0.09 | -0.09 | -0.11 | -0.10 | -0.10 | -0.12 | -0.12 | -0.09 | -0.04 | -0.08 | |||||
| Shares Outstanding | 84.71M | 90.62M | 101.31M | 101.43M | 101.81M | 101.70M | 102.85M | 103.06M | 103.45M | 103.27M | 104.09M | 104.64M | 105.11M | 104.85M | 105.95M | 106.40M | 106.61M | 106.43M | 106.88M | 106.82M | |||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 84.71M | 90.62M | 101.31M | 101.43M | 101.81M | 101.70M | 102.85M | 103.06M | 103.45M | 103.27M | 104.09M | 104.64M | 105.11M | 104.85M | 105.95M | 106.40M | 106.61M | 106.43M | 106.88M | 106.82M | |||||
| EBITDA | -2.44M | -4.96M | -4.16M | -8.74M | -7.71M | -6.75M | -13.18M | -13.07M | -13.95M | -8.10M | -12.28M | -10.89M | -12.99M | -11.84M | -11.21M | -13.14M | -13.09M | -10.17M | -5.16M | -9.27M | |||||
| Interest ExpensesInt Expense | 0.29M | 0.12M | 0.01M |